sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


Global Biosimilar Market Insights, Forecast to 2025

Global Biosimilar Market Insights, Forecast to 2025

Category : Pharmaceuticals and Healthcare QY Research Pages :118
Published Date : 2018-12-31

 

A product is termed as biosimilar product, if it is a biological product with similar characteristics as that of a reference biological product, which possesses approval from agencies such as FDA. There would not be any major clinical difference in effectiveness and safety as that of reference product. Biosimilar products are made of complex molecules with high molecular weight produced through genetic engineering in living cells. Biologics drugs are costlier than respective chemical drugs. Biosimilar drugs can save around 30 to 40 % in terms of price relative to the respective biologics drugs. Biosimilars are useful for the treatment of illnesses such as anemia, autoimmune diseases, cancer, diabetes, growth hormone deficiencies, hematological diseases, kidney failure, rheumatoid arthritis and others. For the manufacturing of biosimilars, manufacturers have to develop environments that are ideal for the living cells, which remain sensitive to environmental conditions. Moreover, they need to develop distinctive process to entice the living cells for producing similar outcome to a prevalent biological treatment. The substitution of biological drugs with biosimilar drugs can save lot of money for public health care sector and patients. The regulatory authorities in developed nations are promoting biosimilar products. The global Biosimilar market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of 25.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Biosimilar market based on company, product type, end user and key regions. This report studies the global market size of Biosimilar in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Biosimilar in these regions. This research report categorizes the global Biosimilar market by top players/brands, region, type and end user. This report also studies the global Biosimilar market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. The following manufacturers are covered in this report, with sales, revenue, market share for each company: Allergan plc BIOCAD Biocon BioXpress Therapeutics Boehringer Ingelheim Celltrion Coherus BioSciences Dr. Reddy’s Laboratories Genor BioPharma Intas Pharmaceuticals Limited Novartis Pfizer Reliance Life Sciences Market size by Product Human Growth Hormones Monoclonal Antibodies Insulin Peptides Erythropoietin Others Market size by End User Oncology Chronic and Autoimmune Diseases Growth Hormone Deficiency Infectious Diseases Others Market size by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Biosimilar market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025. To understand the structure of Biosimilar market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Biosimilar companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. To project the value and sales volume of Biosimilar submarkets, with respect to key regions. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. In this study, the years considered to estimate the market size of Biosimilar are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Biosimilar market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Study Coverage 1.1 Biosimilar Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Biosimilar Market Size Growth Rate by Product 1.4.2 Human Growth Hormones 1.4.3 Monoclonal Antibodies 1.4.4 Insulin 1.4.5 Peptides 1.4.6 Erythropoietin 1.4.7 Others 1.5 Market by End User 1.5.1 Global Biosimilar Market Size Growth Rate by End User 1.5.2 Oncology 1.5.3 Chronic and Autoimmune Diseases 1.5.4 Growth Hormone Deficiency 1.5.5 Infectious Diseases 1.5.6 Others 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Biosimilar Market Size 2.1.1 Global Biosimilar Revenue 2014-2025 2.1.2 Global Biosimilar Sales 2014-2025 2.2 Biosimilar Growth Rate by Regions 2.2.1 Global Biosimilar Sales by Regions 2.2.2 Global Biosimilar Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Biosimilar Sales by Manufacturers 3.1.1 Biosimilar Sales by Manufacturers 3.1.2 Biosimilar Sales Market Share by Manufacturers 3.1.3 Global Biosimilar Market Concentration Ratio (CR5 and HHI) 3.2 Biosimilar Revenue by Manufacturers 3.2.1 Biosimilar Revenue by Manufacturers (2014-2019) 3.2.2 Biosimilar Revenue Share by Manufacturers (2014-2019) 3.3 Biosimilar Price by Manufacturers 3.4 Biosimilar Manufacturing Base Distribution, Product Types 3.4.1 Biosimilar Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Biosimilar Product Type 3.4.3 Date of International Manufacturers Enter into Biosimilar Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global Biosimilar Sales by Product 4.2 Global Biosimilar Revenue by Product 4.3 Biosimilar Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global Biosimilar Breakdown Data by End User 6 North America 6.1 North America Biosimilar by Countries 6.1.1 North America Biosimilar Sales by Countries 6.1.2 North America Biosimilar Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Biosimilar by Product 6.3 North America Biosimilar by End User 7 Europe 7.1 Europe Biosimilar by Countries 7.1.1 Europe Biosimilar Sales by Countries 7.1.2 Europe Biosimilar Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Biosimilar by Product 7.3 Europe Biosimilar by End User 8 Asia Pacific 8.1 Asia Pacific Biosimilar by Countries 8.1.1 Asia Pacific Biosimilar Sales by Countries 8.1.2 Asia Pacific Biosimilar Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Biosimilar by Product 8.3 Asia Pacific Biosimilar by End User 9 Central & South America 9.1 Central & South America Biosimilar by Countries 9.1.1 Central & South America Biosimilar Sales by Countries 9.1.2 Central & South America Biosimilar Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Biosimilar by Product 9.3 Central & South America Biosimilar by End User 10 Middle East and Africa 10.1 Middle East and Africa Biosimilar by Countries 10.1.1 Middle East and Africa Biosimilar Sales by Countries 10.1.2 Middle East and Africa Biosimilar Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Biosimilar by Product 10.3 Middle East and Africa Biosimilar by End User 11 Company Profiles 11.1 Allergan plc 11.1.1 Allergan plc Company Details 11.1.2 Company Business Overview 11.1.3 Allergan plc Biosimilar Sales, Revenue and Gross Margin (2014-2019) 11.1.4 Allergan plc Biosimilar Products Offered 11.1.5 Allergan plc Recent Development 11.2 BIOCAD 11.2.1 BIOCAD Company Details 11.2.2 Company Business Overview 11.2.3 BIOCAD Biosimilar Sales, Revenue and Gross Margin (2014-2019) 11.2.4 BIOCAD Biosimilar Products Offered 11.2.5 BIOCAD Recent Development 11.3 Biocon 11.3.1 Biocon Company Details 11.3.2 Company Business Overview 11.3.Biocon Biosimilar Sales, Revenue and Gross Margin (2014-2019) 11.3.4 Biocon Biosimilar Products Offered 11.3.5 Biocon Recent Development 11.4 BioXpress Therapeutics 11.4.1 BioXpress Therapeutics Company Details 11.4.2 Company Business Overview 11.4.3 BioXpress Therapeutics Biosimilar Sales, Revenue and Gross Margin (2014-2019) 11.4.4 BioXpress Therapeutics Biosimilar Products Offered 11.4.5 BioXpress Therapeutics Recent Development 11.5 Boehringer Ingelheim 11.5.1 Boehringer Ingelheim Company Details 11.5.2 Company Business Overview 11.5.3 Boehringer Ingelheim Biosimilar Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Boehringer Ingelheim Biosimilar Products Offered 11.5.5 Boehringer Ingelheim Recent Development 11.6 Celltrion 11.6.1 Celltrion Company Details 11.6.2 Company Business Overview 11.6.3 Celltrion Biosimilar Sales, Revenue and Gross Margin (2014-2019) 11.6.4 Celltrion Biosimilar Products Offered 11.6.5 Celltrion Recent Development 11.7 Coherus BioSciences 11.7.1 Coherus BioSciences Company Details 11.7.2 Company Business Overview 11.7.3 Coherus BioSciences Biosimilar Sales, Revenue and Gross Margin (2014-2019) 11.7.4 Coherus BioSciences Biosimilar Products Offered 11.7.5 Coherus BioSciences Recent Development 11.8 Dr. Reddy’s Laboratories 11.8.1 Dr. Reddy’s Laboratories Company Details 11.8.2 Company Business Overview 11.8.3 Dr. Reddy’s Laboratories Biosimilar Sales, Revenue and Gross Margin (2014-2019) 11.8.4 Dr. Reddy’s Laboratories Biosimilar Products Offered 11.8.5 Dr. Reddy’s Laboratories Recent Development 11.9 Genor BioPharma 11.9.1 Genor BioPharma Company Details 11.9.2 Company Business Overview 11.9.3 Genor BioPharma Biosimilar Sales, Revenue and Gross Margin (2014-2019) 11.9.4 Genor BioPharma Biosimilar Products Offered 11.9.5 Genor BioPharma Recent Development 11.10 Intas Pharmaceuticals Limited 11.10.1 Intas Pharmaceuticals Limited Company Details 11.10.2 Company Business Overview 11.10.3 Intas Pharmaceuticals Limited Biosimilar Sales, Revenue and Gross Margin (2014-2019) 11.10.4 Intas Pharmaceuticals Limited Biosimilar Products Offered 11.10.5 Intas Pharmaceuticals Limited Recent Development 11.11 Novartis 11.12 Pfizer 11.13 Reliance Life Sciences 12 Future Forecast 12.1 Biosimilar Market Forecast by Regions 12.1.1 Global Biosimilar Sales Forecast by Regions 2019-2025 12.1.2 Global Biosimilar Revenue Forecast by Regions 2019-2025 12.2 Biosimilar Market Forecast by Product 12.2.1 Global Biosimilar Sales Forecast by Product 2019-2025 12.2.2 Global Biosimilar Revenue Forecast by Product 2019-2025 12.3 Biosimilar Market Forecast by End User 12.4 North America Biosimilar Forecast 12.5 Europe Biosimilar Forecast 12.6 Asia Pacific Biosimilar Forecast 12.7 Central & South America Biosimilar Forecast 12.8 Middle East and Africa Biosimilar Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Biosimilar Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

Get Free Sample

List of Tables and Figures Figure Biosimilar Product Picture Table Biosimilar Market Segments Table Key Manufacturers Biosimilar Covered Table Global Biosimilar Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$) Figure Global Biosimilar Sales Market Share by Product 2014-2025 Figure Human Growth Hormones Product Picture Table Major Manufacturers of Human Growth Hormones Figure Monoclonal Antibodies Product Picture Table Major Manufacturers of Monoclonal Antibodies Figure Insulin Product Picture Table Major Manufacturers of Insulin Figure Peptides Product Picture Table Major Manufacturers of Peptides Figure Erythropoietin Product Picture Table Major Manufacturers of Erythropoietin Figure Others Product Picture Table Major Manufacturers of Others Table Global Biosimilar Market Size Growth Rate by End User 2019-2025 (K Units) Figure Oncology Figure Chronic and Autoimmune Diseases Figure Growth Hormone Deficiency Figure Infectious Diseases Figure Others Figure Biosimilar Report Years Considered Figure Global Biosimilar Market Size 2014-2025 (Million US$) Figure Global Biosimilar Sales 2014-2025 (K Units) Table Global Biosimilar Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global Biosimilar Sales by Regions 2014-2019 (K Units) Table Global Biosimilar Sales Market Share by Regions 2014-2019 Figure Global Biosimilar Sales Market Share by Regions 2014-2019 Figure 2018 Global Biosimilar Sales Market Share by Regions Table Global Biosimilar Revenue by Regions 2014-2019 (Million US$) Table Global Biosimilar Revenue Market Share by Regions 2014-2019 Figure Global Biosimilar Revenue Market Share by Regions 2014-2019 Figure 2018 Global Biosimilar Revenue Market Share by Regions Table Global Biosimilar Sales by Manufacturers (2014-2019) (K Units) Table Global Biosimilar Sales Share by Manufacturers (2014-2019) Figure Global Biosimilar Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Biosimilar Revenue by Manufacturers (2014-2019) (Million USD) Table Biosimilar Revenue Share by Manufacturers (2014-2019) Figure Biosimilar Value Share by Manufacturers in 2018 Table Key Manufacturers Biosimilar Price (2014-2019) (USD/Unit) Table Biosimilar Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Biosimilar Product Type Table Date of International Manufacturers Enter into Biosimilar Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Biosimilar Sales by Product (2014-2019) (K Units) Table Global Biosimilar Sales Share by Product (2014-2019) Figure Global Biosimilar Sales Market Share by Product (2014-2019) Figure Global Biosimilar Sales Market Share by Product in 2018 Table Global Biosimilar Revenue by Product (2014-2019) (Million US$) Table Global Biosimilar Revenue Share by Product (2014-2019) Figure Global Biosimilar Revenue Market Share by Product (2014-2019) Figure Global Biosimilar Revenue Market Share by Product in 2018 Table Biosimilar Price by Product 2014-2019 (USD/Unit) Table Global Biosimilar Sales by End User (2014-2019) (K Units) Table Global Biosimilar Sales Share by End User (2014-2019) Figure Global Sales Biosimilar Market Share by End User (2014-2019) Figure Global Sales Biosimilar Market Share by End User in 2018 Figure North America Biosimilar Sales Growth Rate 2014-2019 (K Units) Figure North America Biosimilar Revenue Growth Rate 2014-2019 (Million US$) Table North America Biosimilar Sales by Countries (2014-2019) (K Units) Table North America Biosimilar Sales Market Share by Countries (2014-2019) Figure 2018 North America Biosimilar Sales Market Share by Countries Table North America Biosimilar Revenue by Countries (2014-2019) (Million US$) Table North America Biosimilar Revenue Market Share by Countries (2014-2019) Figure 2018 North America Biosimilar Revenue Market Share by Countries Figure United States Biosimilar Sales Growth Rate (2014-2019) (K Units) Figure United States Biosimilar Revenue Growth Rate (2014-2019) (K Units) Figure Canada Biosimilar Sales Growth Rate (2014-2019) (K Units) Figure Canada Biosimilar Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Biosimilar Sales Growth Rate (2014-2019) (K Units) Figure Mexico Biosimilar Revenue Growth Rate (2014-2019) (Million US$) Table North America Biosimilar Sales by Product (2014-2019) (K Units) Table North America Biosimilar Sales Market Share by Product (2014-2019) Figure 2018 North America Biosimilar Market Share by Product Table North America Biosimilar Sales by End User (2014-2019) (K Units) Table North America Biosimilar Sales Market Share by End User (2014-2019) Figure 2018 North America Biosimilar Market Share by End User Figure Europe Biosimilar Sales Growth Rate 2014-2019 (K Units) Figure Europe Biosimilar Revenue Growth Rate 2014-2019 (Million US$) Table Europe Biosimilar Sales by Countries (2014-2019) (K Units) Table Europe Biosimilar Sales Market Share by Countries (2014-2019) Figure 2018 Europe Biosimilar Sales Market Share by Countries Table Europe Biosimilar Revenue by Countries (2014-2019) (Million US$) Table Europe Biosimilar Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Biosimilar Revenue Market Share by Countries Figure Germany Biosimilar Sales Growth Rate (2014-2019) (K Units) Figure Germany Biosimilar Revenue Growth Rate (2014-2019) (Million US$) Figure France Biosimilar Sales Growth Rate (2014-2019) (K Units) Figure France Biosimilar Revenue Growth Rate (2014-2019) (Million US$) Figure UK Biosimilar Sales Growth Rate (2014-2019) (K Units) Figure UK Biosimilar Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Biosimilar Sales Growth Rate (2014-2019) (K Units) Figure Italy Biosimilar Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Biosimilar Sales Growth Rate (2014-2019) (K Units) Figure Russia Biosimilar Revenue Growth Rate (2014-2019) (Million US$) Table Europe Biosimilar Sales by Product (2014-2019) (K Units) Table Europe Biosimilar Sales Market Share by Product (2014-2019) Figure 2018 Europe Biosimilar Market Share by Product Table Europe Biosimilar Sales by End User (2014-2019) (K Units) Table Europe Biosimilar Sales Market Share by End User (2014-2019) Figure 2018 Europe Biosimilar Market Share by End User Figure Asia Pacific Biosimilar Sales Growth Rate 2014-2019 (K Units) Figure Asia Pacific Biosimilar Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Biosimilar Sales by Countries (2014-2019) (K Units) Table Asia Pacific Biosimilar Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Biosimilar Sales Market Share by Countries Table Asia Pacific Biosimilar Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Biosimilar Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Biosimilar Revenue Market Share by Countries Figure China Biosimilar Sales Growth Rate (2014-2019) (K Units) Figure China Biosimilar Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Biosimilar Sales Growth Rate (2014-2019) (K Units) Figure Japan Biosimilar Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Biosimilar Sales Growth Rate (2014-2019) (K Units) Figure Korea Biosimilar Revenue Growth Rate (2014-2019) (Million US$) Figure India Biosimilar Sales Growth Rate (2014-2019) (K Units) Figure India Biosimilar Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Biosimilar Sales Growth Rate (2014-2019) (K Units) Figure Australia Biosimilar Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Biosimilar Sales Growth Rate (2014-2019) (K Units) Figure Indonesia Biosimilar Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Biosimilar Sales Growth Rate (2014-2019) (K Units) Figure Malaysia Biosimilar Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Biosimilar Sales Growth Rate (2014-2019) (K Units) Figure Philippines Biosimilar Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Biosimilar Sales Growth Rate (2014-2019) (K Units) Figure Thailand Biosimilar Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Biosimilar Sales Growth Rate (2014-2019) (K Units) Figure Vietnam Biosimilar Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Biosimilar Sales Growth Rate (2014-2019) (K Units) Figure Singapore Biosimilar Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Biosimilar Sales by Product (2014-2019) (K Units) Table Asia Pacific Biosimilar Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Biosimilar Market Share by Product Table Asia Pacific Biosimilar Sales by End User (2014-2019) (K Units) Table Asia Pacific Biosimilar Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Biosimilar Market Share by End User Figure Central & South America Biosimilar Sales Growth Rate 2014-2019 (K Units) Figure Central & South America Biosimilar Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Biosimilar Sales by Countries (2014-2019) (K Units) Table Central & South America Biosimilar Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Biosimilar Sales Market Share by Countries Table Central & South America Biosimilar Revenue by Countries (2014-2019) (Million US$) Table Central & South America Biosimilar Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Biosimilar Revenue Market Share by Countries Figure Brazil Biosimilar Sales Growth Rate (2014-2019) (K Units) Figure Brazil Biosimilar Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Biosimilar Sales Growth Rate (2014-2019) (K Units) Figure Argentina Biosimilar Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Biosimilar Sales by Product (2014-2019) (K Units) Table Central & South America Biosimilar Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Biosimilar Market Share by Product Table Central & South America Biosimilar Sales by End User (2014-2019) (K Units) Table Central & South America Biosimilar Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Biosimilar Market Share by End User Figure Middle East and Africa Biosimilar Sales Growth Rate 2014-2019 (K Units) Figure Middle East and Africa Biosimilar Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Biosimilar Sales by Countries (2014-2019) (K Units) Table Middle East and Africa Biosimilar Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Biosimilar Sales Market Share by Countries Table Middle East and Africa Biosimilar Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Biosimilar Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Biosimilar Revenue Market Share by Countries Figure GCC Countries Biosimilar Sales Growth Rate (2014-2019) (K Units) Figure GCC Countries Biosimilar Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Biosimilar Sales Growth Rate (2014-2019) (K Units) Figure Turkey Biosimilar Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Biosimilar Sales Growth Rate (2014-2019) (K Units) Figure Egypt Biosimilar Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Biosimilar Sales Growth Rate (2014-2019) (K Units) Figure South Africa Biosimilar Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Biosimilar Sales by Product (2014-2019) (K Units) Table Middle East and Africa Biosimilar Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Biosimilar Market Share by Product Table Middle East and Africa Biosimilar Sales by End User (2014-2019) (K Units) Table Middle East and Africa Biosimilar Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Biosimilar Market Share by End User Table Allergan plc Company Details Table Allergan plc Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Allergan plc Recent Development Table BIOCAD Company Details Table BIOCAD Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table BIOCAD Recent Development Table Biocon Company Details Table Biocon Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Biocon Recent Development Table BioXpress Therapeutics Company Details Table BioXpress Therapeutics Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table BioXpress Therapeutics Recent Development Table Boehringer Ingelheim Company Details Table Boehringer Ingelheim Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Boehringer Ingelheim Recent Development Table Celltrion Company Details Table Celltrion Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Celltrion Recent Development Table Coherus BioSciences Company Details Table Coherus BioSciences Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Coherus BioSciences Recent Development Table Dr. Reddy’s Laboratories Company Details Table Dr. Reddy’s Laboratories Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Dr. Reddy’s Laboratories Recent Development Table Genor BioPharma Company Details Table Genor BioPharma Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Genor BioPharma Recent Development Table Intas Pharmaceuticals Limited Company Details Table Intas Pharmaceuticals Limited Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Intas Pharmaceuticals Limited Recent Development Table Novartis Company Details Table Pfizer Company Details Table Reliance Life Sciences Company Details Table Global Biosimilar Sales Forecast by Regions 2019-2025 (K Units) Table Global Biosimilar Sales Market Share Forecast by Regions 2019-2025 Table Global Biosimilar Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Biosimilar Revenue Market Share Forecast by Regions 2019-2025 Table Global Biosimilar Sales Forecast by Product 2019-2025 (K Units) Table Global Biosimilar Sales Market Share Forecast by Product 2019-2025 Table Global Biosimilar Revenue Forecast by Product 2019-2025 (Million US$) Table Global Biosimilar Revenue Market Share Forecast by Product 2019-2025 Table Global Biosimilar Sales Forecast by End User 2019-2025 (K Units) Table Global Biosimilar Sales Market Share Forecast by End User 2019-2025 Figure North America Biosimilar Sales Growth Rate Forecast (2019-2025) (K Units) Figure North America Biosimilar Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Biosimilar Sales Growth Rate Forecast (2019-2025) (K Units) Figure Europe Biosimilar Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Biosimilar Sales Growth Rate Forecast (2019-2025) (K Units) Figure Asia Pacific Biosimilar Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Biosimilar Sales Growth Rate Forecast (2019-2025) (K Units) Figure Central & South America Biosimilar Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Biosimilar Sales Growth Rate Forecast (2019-2025) (K Units) Figure Middle East and Africa Biosimilar Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Biosimilar Value Chain Table Biosimilar Customers List Table Biosimilar Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Get Free Sample

Related Reports

Global Biosimilar Market Insights, Forecast to 2025

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

Global Biosimilar Market Insights, Forecast to 2025

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

Global Biosimilar Market Insights, Forecast to 2025

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

Global Biosimilar Market Insights, Forecast to 2025

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

Global Biosimilar Market Insights, Forecast to 2025

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)